RU2119536C1 - Strain escherichia coli - a producer of l-histidine - Google Patents

Strain escherichia coli - a producer of l-histidine Download PDF

Info

Publication number
RU2119536C1
RU2119536C1 RU97101043A RU97101043A RU2119536C1 RU 2119536 C1 RU2119536 C1 RU 2119536C1 RU 97101043 A RU97101043 A RU 97101043A RU 97101043 A RU97101043 A RU 97101043A RU 2119536 C1 RU2119536 C1 RU 2119536C1
Authority
RU
Russia
Prior art keywords
histidine
strain
coli
producer
escherichia coli
Prior art date
Application number
RU97101043A
Other languages
Russian (ru)
Other versions
RU97101043A (en
Inventor
Е.В. Клячко
М.Г. Зиброва
Р.С. Шакулов
В.Г. Дебабов
Ю.И. Козлов
Original Assignee
Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов filed Critical Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов
Priority to RU97101043A priority Critical patent/RU2119536C1/en
Application granted granted Critical
Publication of RU2119536C1 publication Critical patent/RU2119536C1/en
Publication of RU97101043A publication Critical patent/RU97101043A/en

Links

Images

Abstract

FIELD: microbiology, biotechnology. SUBSTANCE: invention proposes a new strain Escherichia coli VKPM B-7270 as a producer of L-histidine. Strain is obtained by selection of new mutation in gene hisG of histidine operon and the following insertion of extraoperon mutations in it that enhance the expression of histidine operon. The indicated strain is resistant to sulfaguanidine, D,L-1,2,4-triazole-3-alanine and streptomycin and ensures to obtain L-histidine at yield 16-17 g/l. Conversion degree of glucose to histidine is 24-26%. EFFECT: new strain indicated above, increased yield of L-histidine. 1 tbl, 1 ex

Description

Изобретение относится к микробиологической промышленности и представляет собой новый штамм бактерии Escherichia coli, продуцирующих аминокислоту гистидин. L-гистидин - незаменимая аминокислота, используемая в качестве компонента питательных смесей медицинского назначения и ростового фактора для ряда продуцентов первичных метаболитов. В химической и фармацевтической промышленности гистидин используется для получения препаратов гистамина и урокановой кислоты. The invention relates to the microbiological industry and is a new strain of the bacterium Escherichia coli producing histidine amino acid. L-histidine is an essential amino acid used as a component of nutritional mixtures for medical purposes and growth factor for a number of producers of primary metabolites. In the chemical and pharmaceutical industries, histidine is used to produce histamine and urocanic acid.

Известны штаммы-продуценты гистидина, принадлежащие к различным видам микроорганизмов (Corynebacterium glutamicum, Corynebacterium herculis, Corynebacterium acetoacidophilum, Brevibacterium flavum, Brevibacterium lactofermentum, Escherichia coli, Arthrobacter citreum, Nocardia globerula, Bacillus subtilis, Microbacterium ammoniaphilum, Serratia marcescens) (патент США 37136977; патент США 3716453; патент США 5294547; патент Японии 61 - 41554; патент США 4388405; Sigiura M. , Kisumi M., 1984, Appl. Environ. Microbiol. v. 48, p. 43 - 49; Mizukami T., Hamu A., Ikeda M., Oka T., Katsumata R. , 1994, Bioscience, Biotech. Biochem., v. 58, p. 635 - 638). Наиболее эффективными продуцентами гистидина являются плазмидные штаммы Serratia marcescens (патент Японии 61-271981). Эти продуценты содержат мутантный гистидиновый оперон или его фрагмент в составе низкокопийной плазмиды и способны накапливать за 120 ч до 45 г/л гистидина. Однако недостатками плазмидных штаммов - продуцентов гистидина является необходимость добавления антибиотиков в ферментационную среду для поддержания плазмиды с клонированным геном, замедленный рост плазмидных продуцентов и вследствие этого увеличение продолжительности ферментации. До настоящего времени не были получены эффективные продуценты гистидина среди представителей E. coli. Известен бесплазмидный штамм E. coli 24 (патент РФ 2003677), продуцирующий 10 - 12 г/л гистидина за 72 ч ферментации в лабораторных условиях. Этот штамм выбран нами в качестве прототипа. Недостатком штамма-прототипа является его низкая продуктивность и низкая конверсия глюкозы в гистидин, которая составляет 18 - 20%. Histidine producing strains belonging to various types of microorganisms (Corynebacterium glutamicum, Corynebacterium herculis, Corynebacterium acetoacidophilum, Brevibacterium flavum, Brevibacterium lactofermentum, Escherichia coli, Arthrobacterium bacillus fibrobius, Arthrobacterium bacterium bacterium US patent 3716453; US patent 5294547; Japan patent 61 - 41554; US patent 4388405; Sigiura M., Kisumi M., 1984, Appl. Environ. Microbiol. v. 48, p. 43 - 49; Mizukami T., Hamu A ., Ikeda M., Oka T., Katsumata R., 1994, Bioscience, Biotech. Biochem., V. 58, p. 635-638). The most effective histidine producers are plasmid strains of Serratia marcescens (Japanese Patent 61-271981). These producers contain a mutant histidine operon or its fragment in the composition of a low copy plasmid and are capable of accumulating up to 45 g / l histidine in 120 hours. However, the disadvantages of the plasmid strains producing histidine are the need to add antibiotics to the fermentation medium to maintain the plasmid with the cloned gene, the slow growth of plasmid producers and, as a consequence, the increase in the duration of fermentation. To date, effective histidine producers have not been obtained among representatives of E. coli. Known plasmid-free strain of E. coli 24 (RF patent 2003677), producing 10 to 12 g / l of histidine for 72 hours of fermentation in laboratory conditions. This strain is selected by us as a prototype. The disadvantage of the strain of the prototype is its low productivity and low conversion of glucose to histidine, which is 18 to 20%.

Задачей изобретения является создание бесплазмидного штамма E. coli с более высокой продуктивностью и повышенной конверсией глюкозы в L-гистидин. Задача достигается созданием нового штамма E. coli 80, который за 68 ч ферментации в лабораторных условиях накапливает в среде 16 - 17 г/л гистидина, конверсия глюкозы в гистидин составляет 25%. The objective of the invention is the creation of a plasmid-free strain of E. coli with higher productivity and increased conversion of glucose to L-histidine. The objective is achieved by creating a new strain of E. coli 80, which accumulates 16-17 g / l of histidine in the laboratory for 68 hours of fermentation under laboratory conditions; the conversion of glucose to histidine is 25%.

Штамм E. coli 80 получен путем направленной селекции с применением N-метил-N'-нитро-N-нитрозогуанидина в качестве мутагенного фактора. В качестве исходного штамма использован штамм E. coli CC14, описанный нами ранее (Чахмахчян С.С., Клячко Е.В., Шакулов Р.С., Домкин В.Д., 1992, Молек. генетика, микробиология и вирусология, с. 15 - 18). Этот штамм содержит гистидиновый оперон дикого типа и не продуцирует гистидин. Новый штамм E. coli 80 отличается от исходного тремя особенностями: мутацией в гене hisG, обуславливающей резистентность первого фермента пути биосинтеза гистидина АТФ-фосфорибозилтрансферазы к смеси гистидина и сульфагуанидина, усилением транскрипции гистидинового оперона, а также внесением рибосомной мутации, обеспечивающей резистентность к стрептомицину. The strain E. coli 80 was obtained by targeted selection using N-methyl-N'-nitro-N-nitrosoguanidine as a mutagenic factor. The strain E. coli CC14, which we described earlier (Chakhmakhchyan S.S., Klyachko E.V., Shakulov R.S., Domkin V.D., 1992, Molecular Genetics, Microbiology and Virology, s. . 15 - 18). This strain contains a wild-type histidine operon and does not produce histidine. The new E. coli 80 strain differs from the initial one in three features: a mutation in the hisG gene, which determines the resistance of the first enzyme of the histidine ATP-phosphoribosyltransferase biosynthesis pathway to a mixture of histidine and sulfaguanidine, enhances the transcription of the histidine operon, and also introduces ribosome resistance.

Для получения E. coli 80 исходный штамм Escherichia coli CC14 обрабатывают N-метил-N'-нитро-N- нитрозогуанидином по стандартной методике (Миллер Дж. , Эксперименты в молекулярной генетике. - М.: Мир, 1976). Среди штаммов, резистентных к 500 мкг/мл гистидина и 50 мкг/мл сульфагуанидина, отбирают штаммы, способные к накоплению гистидина в культуральной жидкости. В один из них названный E. coli 70 с помощью фага P1 из E. coli CP 78 (Fiil N., Friesen J. D., 1968, J. Bacteriol., v. 95, p. 729 - 731) переносят дикий аллель гена purF. Используя штамм E. coli 70 (purF+) в качестве родительского, получают клоны, резистентные к аналогу гистидина D,L-1,2,4-триазол-3-аланину (TPA) и стрептомицину. Среди этих клонов отбирают штамм с повышенной способностью продуцировать гистидин, названный E. coli 80. To obtain E. coli 80, the original strain of Escherichia coli CC14 is treated with N-methyl-N'-nitro-N-nitrosoguanidine according to the standard procedure (Miller J., Experiments in molecular genetics. - M .: Mir, 1976). Among the strains resistant to 500 μg / ml histidine and 50 μg / ml sulfaguanidine, strains capable of histidine accumulation in the culture fluid are selected. In one of them, named E. coli 70, the wild allele of the purF gene is transferred using phage P1 from E. coli CP 78 (Fiil N., Friesen J. D., 1968, J. Bacteriol., V. 95, p. 729-731). Using E. coli 70 strain (purF +) as the parent, clones resistant to the histidine analog D, L-1,2,4-triazole-3-alanine (TPA) and streptomycin are obtained. Among these clones, a histidine producing strain named E. coli 80 was selected.

Новый продуцент гистидина E. coli 80 депонирован во Всесоюзной коллекции промышленных микроорганизмов под регистрационным номером ВКПМ B-7270. The new histidine producer E. coli 80 is deposited in the All-Union Collection of Industrial Microorganisms under registration number VKPM B-7270.

Новый штамм E. coli ВКПМ B-7270 имеет следующие культурально-морфологические и биохимические признаки. The new strain of E. coli VKPM B-7270 has the following cultural, morphological and biochemical characteristics.

Культурально-морфологические признаки. Грамотрицательная слабоподвижная палочка с закругленными концами длиной 1,5 - 2,0 мкм. Спор не образует. Cultural and morphological characters. Gram-negative, slightly movable rod with rounded ends 1.5 - 2.0 microns in length. The dispute does not form.

На полноценной агаризованной среде (агар Луриа, агар Хоттингера) через 48 ч, а на синтетической среде через 72 ч инкубации при 30oC образует круглые беловатые полупрозрачные колонии диаметром 2 мм. Поверхность колоний гладкая, края ровные, центр колоний приподнят, структура однородная, консистенция пастообразная, легко эмульгируются.On a full-fledged agar medium (Luria agar, Hottinger agar) after 48 h, and on a synthetic medium after 72 h incubation at 30 o C forms round whitish translucent colonies with a diameter of 2 mm. The surface of the colonies is smooth, the edges are even, the center of the colonies is raised, the structure is homogeneous, the consistency is pasty, easily emulsified.

На синтетической среде клетки продуцента требуют витамин B1, а также L-пролин. On a synthetic medium, producer cells require vitamin B1 as well as L-Proline.

Штамм поддерживают на чашках с плотной синтетической солевой средой следующего состава, г/л:
Глюкоза - 10,0
Трис-(оксиметил)-аминометан - 6,05
Сульфат аммония - 2,0
Сульфат магния - 0,2
Цитрат натрия - 1,0
Калий хлористый - 2,0
Калий фосфорно-кислый однозамещенный - 0,028
Тиамин - 0,002
Пролин - 0,1
Стрептомицин - 1,0
Агар - 20
Вода дистиллированная до 1 л pH - 7,4 - 7,6
Физиолого-биохимические признаки. Штамм является ауксотрофом по пролину.
The strain is maintained on plates with a dense synthetic salt medium of the following composition, g / l:
Glucose - 10.0
Tris- (hydroxymethyl) -aminomethane - 6.05
Ammonium Sulfate - 2.0
Magnesium Sulfate - 0.2
Sodium Citrate - 1.0
Potassium chloride - 2.0
Potassium phosphoric acid monosubstituted - 0.028
Thiamine - 0.002
Proline - 0.1
Streptomycin - 1.0
Agar - 20
Distilled water to 1 liter pH - 7.4 - 7.6
Physiological and biochemical characteristics. The strain is an auxotroph along the proline.

Факультативный анаэроб. При посеве уколом в полноценный агар хороший рост по всему уколу. Желатину не разжижает. Усваивает глюкозу, мальтозу, маннит, галактозу, сорбит, глицерин. Не потребляет сахарозу, лактозу, рафинозу. Optional anaerobic. When sowing by injection in full agar, good growth throughout the injection. It does not dilute gelatin. Absorbs glucose, maltose, mannitol, galactose, sorbitol, glycerin. Does not consume sucrose, lactose, raffinose.

Устойчив к стрептомицину. Resistant to streptomycin.

Содержит мутацию по гену hisG, следствием которой является десенсибилизация АТФ-фосфорибозилтрансферазы в отношении гистидина. It contains a mutation in the hisG gene, which results in the desensitization of ATP-phosphoribosyltransferase against histidine.

Усваивает азот в форме аммония, нитратов, а также азот некоторых органических соединений. Absorbs nitrogen in the form of ammonium, nitrates, and also nitrogen of some organic compounds.

Растет при температуре 43oC и ниже. Оптимальной для роста является температура 37oC, а для продукции гистидина - 29 - 30oC.It grows at a temperature of 43 o C and below. The optimum temperature for growth is 37 o C, and for the production of histidine - 29 - 30 o C.

Растет на жидких средах с pH от 6,0 до 8,0. Оптимальное значение pH 7,0. It grows on liquid media with a pH of 6.0 to 8.0. The optimum pH value is 7.0.

Штамм за 68 ч ферментации накапливает 16 - 17 г/л гистидина. The strain accumulates 16-17 g / l histidine in 68 hours of fermentation.

Хранение штамма. Посевной материал смешивают с равным объемом 80% глицерина и хранят при -70oC.Strain storage. The seed is mixed with an equal volume of 80% glycerol and stored at -70 o C.

Пример 1. Культуры штаммов E. coli 80 и E. coli 24 выращивают на минимальной агаризованной среде при 29oC в течение 65 ч. Для получения посевного материала культуры засевают в пробирки объемом 50 мл, содержащие 2 мл посевной среды следующего состава, г/л:
Глюкоза - 56
Аммоний серно-кислый - 28
Калий фосфорно-кислый однозамещенный - 2,25
Магний серно-кислый, 7-водный - 1,125
Железо (II) серно-кислое, 7-водное - 0,01
Марганец (II) серно-кислый, 4-водный - 0,01
Тиамин - 0,001
Автолизат дрожжей - 2,8
Пролин - 0,3
Стрептомицин - 1,0
Вода дистиллированная до 1 л pH - 6,0
Культивирование проводят в течение 20 ч на термостатируемой круговой качалке (200 - 240 об./мин) при 20oC.
Example 1. Cultures of strains of E. coli 80 and E. coli 24 are grown on a minimal agar medium at 29 ° C for 65 hours. To obtain seed, cultures are seeded in 50 ml tubes containing 2 ml of seed medium of the following composition, g / l:
Glucose - 56
Ammonium Sulfuric Acid - 28
Potassium phosphoric acid monosubstituted - 2.25
Magnesium Sulfuric Acid, 7-water - 1.125
Iron (II) sulfuric acid, 7-water - 0.01
Manganese (II) sulfuric acid, 4-water - 0.01
Thiamine - 0.001
Yeast Autolysate - 2.8
Proline - 0.3
Streptomycin - 1.0
Distilled water to 1 liter pH - 6.0
The cultivation is carried out for 20 hours on a thermostatically controlled circular rocking chair (200 - 240 rpm.) At 20 o C.

Выращенный посевной материал в количестве 5 об.% вносят в ферментационную среду. Ферментационная среда имеет следующий состав, г/л:
Глюкоза - 92
Аммоний серно-кислый - 28
Калий фосфорно-кислый однозамещенный - 2,25
Магний серно-кислый, 7-водный - 1,125
Железо (II) серно-кислое, 7-водное - 0,01
Марганец (II) серно-кислый, 4-водный - 0,01
Тиамин - 0,001
Автолизат дрожжей - 2,8
Пролин - 1,0
Стрептомицин - 1,0
Мел - 65
Вода дистиллированная до 1 л pH - 6,0
Культивирование проводят в микробиологических пробирках объемом 50 мл, содержащих 2 мл ферментационной среды. Через 68 ч культивирования на круговой качалке (350 об./мин) при 29oC в культуральной среде определяют содержание гистидина методом бумажной хроматографии с последующим окрашиванием нингидрином.
The grown seed in an amount of 5 vol.% Contribute to the fermentation medium. The fermentation medium has the following composition, g / l:
Glucose - 92
Ammonium Sulfuric Acid - 28
Potassium phosphoric acid monosubstituted - 2.25
Magnesium Sulfuric Acid, 7-water - 1.125
Iron (II) sulfuric acid, 7-water - 0.01
Manganese (II) sulfuric acid, 4-water - 0.01
Thiamine - 0.001
Yeast Autolysate - 2.8
Proline - 1.0
Streptomycin - 1.0
Chalk - 65
Distilled water to 1 liter pH - 6.0
Cultivation is carried out in 50 ml microbiological tubes containing 2 ml of fermentation medium. After 68 h of cultivation on a circular shaker (350 rpm./min) at 29 o C in the culture medium determine the content of histidine by paper chromatography, followed by staining with ninhydrin.

Результаты ферментации приведены в таблице. The fermentation results are shown in the table.

Claims (1)

Штамм бактерий Escherichia coli ВКПМ B-7270 - продуцент L-гистидина. The bacterial strain Escherichia coli VKPM B-7270 is a producer of L-histidine.
RU97101043A 1997-01-21 1997-01-21 Strain escherichia coli - a producer of l-histidine RU2119536C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97101043A RU2119536C1 (en) 1997-01-21 1997-01-21 Strain escherichia coli - a producer of l-histidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97101043A RU2119536C1 (en) 1997-01-21 1997-01-21 Strain escherichia coli - a producer of l-histidine

Publications (2)

Publication Number Publication Date
RU2119536C1 true RU2119536C1 (en) 1998-09-27
RU97101043A RU97101043A (en) 1999-01-27

Family

ID=20189296

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97101043A RU2119536C1 (en) 1997-01-21 1997-01-21 Strain escherichia coli - a producer of l-histidine

Country Status (1)

Country Link
RU (1) RU2119536C1 (en)

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004254694A (en) * 2003-02-26 2004-09-16 Ajinomoto Co Inc Method for production of l-amino acids by fermentation of glucose and pentose mixture
WO2007100009A1 (en) 2006-03-03 2007-09-07 Ajinomoto Co., Inc. Method for production of l-amino acid
WO2007119890A1 (en) 2006-04-18 2007-10-25 Ajinomoto Co., Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE sfmACDFH-fimZ CLUSTER OR THE fimZ GENE
WO2007125954A1 (en) 2006-04-28 2007-11-08 Ajinomoto Co., Inc. Microorganism capable of producing l-amino acid, and process for production of l-amino acid
US7300786B2 (en) 2003-07-16 2007-11-27 Ajinomoto Co., Inc. Bacteria of the Enterobacteriaceae family having enhanced transaldolase activity
WO2007136133A1 (en) 2006-05-23 2007-11-29 Ajinomoto Co., Inc. A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family
WO2008090770A1 (en) 2007-01-22 2008-07-31 Ajinomoto Co., Inc. Microorganism capable of producing l-amino acid, and method for production of l-amino acid
WO2008093829A1 (en) 2007-02-01 2008-08-07 Ajinomoto Co., Inc. Method for production of l-amino acid
WO2008102861A1 (en) 2007-02-22 2008-08-28 Ajinomoto Co., Inc. Method of producing l-amino acid
EP2055771A2 (en) 2006-03-23 2009-05-06 Ajinomoto Co., Inc. A method for producing an L-amino acid using bacterium of the Enterobacteriaceae family with attenuated expression of a gene coding for small RNA
DE102008049533A1 (en) 2007-09-27 2009-06-18 Ajinomoto Co., Inc. A method for producing amino acids using a bacterium of the family Enterobacteriaceae
WO2009088049A1 (en) 2008-01-10 2009-07-16 Ajinomoto Co., Inc. Method for production of desired substance by fermentation process
WO2009093703A1 (en) 2008-01-23 2009-07-30 Ajinomoto Co., Inc. Method of producing l-amino acid
EP2093291A1 (en) 2008-02-19 2009-08-26 Ajinomoto Co., Inc. A method for constructing an operon containing translationally coupled genes
WO2010027045A1 (en) 2008-09-08 2010-03-11 味の素株式会社 Microorganism capable of producing l-amino acid, and method for producing l-amino acid
WO2010084995A2 (en) 2009-01-23 2010-07-29 Ajinomoto Co.,Inc. A method for producing an l-amino acid
WO2011013707A1 (en) 2009-07-29 2011-02-03 味の素株式会社 Method for producing l-amino acid
EP2345667A2 (en) 2010-01-15 2011-07-20 Ajinomoto Co., Inc. A method for producing an L-amino acid using a bacterium of the enterobacteriaceae family
WO2011096554A1 (en) 2010-02-08 2011-08-11 味の素株式会社 MANUFACTURING METHOD FOR MUTANT rpsA GENE AND L-AMINO ACID
WO2011102305A2 (en) 2010-02-18 2011-08-25 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE Enterobacteriaceae FAMILY HAVING A MUTANT ADENYLATE CYCLASE
WO2012011595A1 (en) 2010-07-21 2012-01-26 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY HAVING ATTENUATED EXPRESSION OF THE astCADBE OPERON
WO2012011596A1 (en) 2010-07-21 2012-01-26 Ajinomoto Co.,Inc. A method for producing an l- amino acid using a bacterium of the enterobacteriaceae family with enhanced expression of the bssr gene
EP2460873A1 (en) 2006-12-12 2012-06-06 Ajinomoto Co., Inc. A method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family with attenuated expression of any of the cynT, cynS, cynX or cynR genes or a combination thereof
WO2012077739A1 (en) 2010-12-10 2012-06-14 味の素株式会社 Method for producing l-amino acid
US8372606B2 (en) 2006-12-25 2013-02-12 Ajinomoto Co., Inc. Methods for obtaining crystals of a basic amino acid hydrochloride
EP2559754A2 (en) 2011-08-18 2013-02-20 Ajinomoto Co., Inc. Method for producing an L-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes
WO2014029376A1 (en) 2012-08-22 2014-02-27 Forschungszentrum Jülich GmbH Method for producing vectors containing a gene that codes for an enzyme having reduced or switched-off feedback inhibition, and use thereof for producing amino acids and nucleotides
EP2796560A1 (en) 2013-04-23 2014-10-29 Ajinomoto Co., Inc. A method for producing an L-amino acid using a bacterium of the family Enterobacteriaceae having attenuated expression of the yjjK gene
WO2014185430A1 (en) 2013-05-13 2014-11-20 味の素株式会社 Method for manufacturing l-amino acid
WO2015030019A1 (en) 2013-08-30 2015-03-05 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING ATTENUATED EXPRESSION OF THE znuACB GENE CLUSTER
WO2015041265A1 (en) 2013-09-17 2015-03-26 味の素株式会社 Method for producing l-amino acid from seaweed-derived biomass
WO2015050234A1 (en) 2013-10-02 2015-04-09 味の素株式会社 Ammonia control apparatus and ammonia control method
WO2015050276A1 (en) 2013-10-02 2015-04-09 Ajinomoto Co.,Inc. A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having attenuated expression of a phosphate transporter-encoding gene
US9005577B2 (en) 2008-04-30 2015-04-14 Siemens Medical Solutions Usa, Inc. Substrate based PET imaging agents
WO2015060314A1 (en) 2013-10-21 2015-04-30 味の素株式会社 Method for producing l-amino acid
WO2015060391A1 (en) 2013-10-23 2015-04-30 味の素株式会社 Method for producing target substance
WO2015122544A1 (en) 2014-02-14 2015-08-20 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING OVEREXPRESSED THE yajL GENE
EP3098319A1 (en) 2015-05-28 2016-11-30 Ajinomoto Co., Inc. A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having an attenuated expression of a gsha gene
WO2017146195A1 (en) 2016-02-25 2017-08-31 Ajinomoto Co., Inc. A method for producing l-amino acids using a bacterium of the family enterobacteriaceae overexpressing a gene encoding an iron exporter
EP3385389A1 (en) 2017-04-03 2018-10-10 Ajinomoto Co., Inc. Method for producing l-amino acid from fructose
WO2020071538A1 (en) 2018-10-05 2020-04-09 Ajinomoto Co., Inc. Method for producing target substance by bacterial fermentation
WO2020138178A1 (en) 2018-12-27 2020-07-02 Ajinomoto Co., Inc. Method for producing basic l-amino acids or salts thereof by fermentation of an enterobacteriaceae bacterium
WO2020171227A1 (en) 2019-02-22 2020-08-27 Ajinomoto Co., Inc. METHOD FOR PRODUCING L-AMINO ACIDS USING A BACTERIUM BELONGING TO THE FAMILY Enterobacteriaceae HAVING OVEREXPRESSED ydiJ GENE
WO2020204179A1 (en) 2019-04-05 2020-10-08 Ajinomoto Co., Inc. Method of producing l-amino acids
WO2021060438A1 (en) 2019-09-25 2021-04-01 Ajinomoto Co., Inc. Method for producing l-amino acids by bacterial fermentation

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004254694A (en) * 2003-02-26 2004-09-16 Ajinomoto Co Inc Method for production of l-amino acids by fermentation of glucose and pentose mixture
US7300786B2 (en) 2003-07-16 2007-11-27 Ajinomoto Co., Inc. Bacteria of the Enterobacteriaceae family having enhanced transaldolase activity
US7399618B2 (en) 2003-07-16 2008-07-15 Ajinomoto Co., Inc. Method for producing L-histidine using bacteria of Enterobacteriaceae family
WO2007100009A1 (en) 2006-03-03 2007-09-07 Ajinomoto Co., Inc. Method for production of l-amino acid
EP2351830A1 (en) 2006-03-23 2011-08-03 Ajinomoto Co., Inc. A method for producing an L-amino acid using bacterium of the Enterobacteriaceae family with attenuated expression of a gene coding for small RNA
EP2055771A2 (en) 2006-03-23 2009-05-06 Ajinomoto Co., Inc. A method for producing an L-amino acid using bacterium of the Enterobacteriaceae family with attenuated expression of a gene coding for small RNA
WO2007119890A1 (en) 2006-04-18 2007-10-25 Ajinomoto Co., Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE sfmACDFH-fimZ CLUSTER OR THE fimZ GENE
WO2007125954A1 (en) 2006-04-28 2007-11-08 Ajinomoto Co., Inc. Microorganism capable of producing l-amino acid, and process for production of l-amino acid
WO2007136133A1 (en) 2006-05-23 2007-11-29 Ajinomoto Co., Inc. A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family
EP2460873A1 (en) 2006-12-12 2012-06-06 Ajinomoto Co., Inc. A method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family with attenuated expression of any of the cynT, cynS, cynX or cynR genes or a combination thereof
US8372606B2 (en) 2006-12-25 2013-02-12 Ajinomoto Co., Inc. Methods for obtaining crystals of a basic amino acid hydrochloride
WO2008090770A1 (en) 2007-01-22 2008-07-31 Ajinomoto Co., Inc. Microorganism capable of producing l-amino acid, and method for production of l-amino acid
WO2008093829A1 (en) 2007-02-01 2008-08-07 Ajinomoto Co., Inc. Method for production of l-amino acid
WO2008102861A1 (en) 2007-02-22 2008-08-28 Ajinomoto Co., Inc. Method of producing l-amino acid
DE102008049533A1 (en) 2007-09-27 2009-06-18 Ajinomoto Co., Inc. A method for producing amino acids using a bacterium of the family Enterobacteriaceae
EP2749652A2 (en) 2008-01-10 2014-07-02 Ajinomoto Co., Inc. A method for producing a target substance by fermentation
WO2009088049A1 (en) 2008-01-10 2009-07-16 Ajinomoto Co., Inc. Method for production of desired substance by fermentation process
WO2009093703A1 (en) 2008-01-23 2009-07-30 Ajinomoto Co., Inc. Method of producing l-amino acid
EP2093291A1 (en) 2008-02-19 2009-08-26 Ajinomoto Co., Inc. A method for constructing an operon containing translationally coupled genes
US10821196B2 (en) 2008-04-30 2020-11-03 Siemens Medical Solutions Usa, Inc. Substrate based PET imaging agents
US9005577B2 (en) 2008-04-30 2015-04-14 Siemens Medical Solutions Usa, Inc. Substrate based PET imaging agents
WO2010027045A1 (en) 2008-09-08 2010-03-11 味の素株式会社 Microorganism capable of producing l-amino acid, and method for producing l-amino acid
WO2010084995A2 (en) 2009-01-23 2010-07-29 Ajinomoto Co.,Inc. A method for producing an l-amino acid
WO2011013707A1 (en) 2009-07-29 2011-02-03 味の素株式会社 Method for producing l-amino acid
EP2345667A2 (en) 2010-01-15 2011-07-20 Ajinomoto Co., Inc. A method for producing an L-amino acid using a bacterium of the enterobacteriaceae family
WO2011096554A1 (en) 2010-02-08 2011-08-11 味の素株式会社 MANUFACTURING METHOD FOR MUTANT rpsA GENE AND L-AMINO ACID
WO2011102305A2 (en) 2010-02-18 2011-08-25 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE Enterobacteriaceae FAMILY HAVING A MUTANT ADENYLATE CYCLASE
WO2012011595A1 (en) 2010-07-21 2012-01-26 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY HAVING ATTENUATED EXPRESSION OF THE astCADBE OPERON
WO2012011596A1 (en) 2010-07-21 2012-01-26 Ajinomoto Co.,Inc. A method for producing an l- amino acid using a bacterium of the enterobacteriaceae family with enhanced expression of the bssr gene
WO2012077739A1 (en) 2010-12-10 2012-06-14 味の素株式会社 Method for producing l-amino acid
WO2013024904A1 (en) 2011-08-18 2013-02-21 Ajinomoto Co.,Inc. A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes
EP2559754A2 (en) 2011-08-18 2013-02-20 Ajinomoto Co., Inc. Method for producing an L-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes
US9644226B2 (en) 2012-08-22 2017-05-09 Forschungszentrum Juelich Gmbh Method for producing vectors containing a gene coding for an enzyme having reduced or deactivated feedback inhibition and the use thereof for producing amino acids and nucleotides
WO2014029376A1 (en) 2012-08-22 2014-02-27 Forschungszentrum Jülich GmbH Method for producing vectors containing a gene that codes for an enzyme having reduced or switched-off feedback inhibition, and use thereof for producing amino acids and nucleotides
DE102012016716A1 (en) 2012-08-22 2014-02-27 Forschungszentrum Jülich GmbH A process for the preparation of vectors comprising a gene coding for an enzyme which has been reduced or eliminated in its feedback inhibition and the use thereof for the production of amino acids and nucleotides
EP2796560A1 (en) 2013-04-23 2014-10-29 Ajinomoto Co., Inc. A method for producing an L-amino acid using a bacterium of the family Enterobacteriaceae having attenuated expression of the yjjK gene
WO2014185430A1 (en) 2013-05-13 2014-11-20 味の素株式会社 Method for manufacturing l-amino acid
WO2015030019A1 (en) 2013-08-30 2015-03-05 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING ATTENUATED EXPRESSION OF THE znuACB GENE CLUSTER
WO2015041265A1 (en) 2013-09-17 2015-03-26 味の素株式会社 Method for producing l-amino acid from seaweed-derived biomass
WO2015050234A1 (en) 2013-10-02 2015-04-09 味の素株式会社 Ammonia control apparatus and ammonia control method
WO2015050276A1 (en) 2013-10-02 2015-04-09 Ajinomoto Co.,Inc. A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having attenuated expression of a phosphate transporter-encoding gene
WO2015060314A1 (en) 2013-10-21 2015-04-30 味の素株式会社 Method for producing l-amino acid
WO2015060391A1 (en) 2013-10-23 2015-04-30 味の素株式会社 Method for producing target substance
WO2015122544A1 (en) 2014-02-14 2015-08-20 Ajinomoto Co.,Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING OVEREXPRESSED THE yajL GENE
EP3098319A1 (en) 2015-05-28 2016-11-30 Ajinomoto Co., Inc. A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having an attenuated expression of a gsha gene
WO2017146195A1 (en) 2016-02-25 2017-08-31 Ajinomoto Co., Inc. A method for producing l-amino acids using a bacterium of the family enterobacteriaceae overexpressing a gene encoding an iron exporter
EP3385389A1 (en) 2017-04-03 2018-10-10 Ajinomoto Co., Inc. Method for producing l-amino acid from fructose
WO2020071538A1 (en) 2018-10-05 2020-04-09 Ajinomoto Co., Inc. Method for producing target substance by bacterial fermentation
WO2020138178A1 (en) 2018-12-27 2020-07-02 Ajinomoto Co., Inc. Method for producing basic l-amino acids or salts thereof by fermentation of an enterobacteriaceae bacterium
WO2020171227A1 (en) 2019-02-22 2020-08-27 Ajinomoto Co., Inc. METHOD FOR PRODUCING L-AMINO ACIDS USING A BACTERIUM BELONGING TO THE FAMILY Enterobacteriaceae HAVING OVEREXPRESSED ydiJ GENE
WO2020204179A1 (en) 2019-04-05 2020-10-08 Ajinomoto Co., Inc. Method of producing l-amino acids
WO2021060438A1 (en) 2019-09-25 2021-04-01 Ajinomoto Co., Inc. Method for producing l-amino acids by bacterial fermentation

Similar Documents

Publication Publication Date Title
RU2119536C1 (en) Strain escherichia coli - a producer of l-histidine
RU2182173C2 (en) Method of production of l-amino acid
US6110714A (en) Process for producing L-glutamic acid by fermentation
FI92717B (en) The bacterial strain of Escheria coli VKPM /BK <IMAGE> M/ B-3996 as a L-treonin producer
RU2140450C1 (en) Strains of bacterium escherichia coli - producers of l-leucine (variants)
EP1561811B1 (en) Method of producing L-threonine using a microorganism having inactivated galR gene.
US6132999A (en) L-threonine-producing microbacteria and a method for the production of L-threonine
CN1165193A (en) Process for producing L-glutamic acid by fermentation
SK10142000A3 (en) L-lysine producing coryneform bacteria and methods for the production of l-lysine
RU2305132C2 (en) MICROORGANISM WITH KNOCKED fadR GENE ON CHROMOSOME AND METHOD FOR PRODUCTION OF L-THREONINE BY FERMENTATION USING SUCH MUTANT
EP1347057B1 (en) Method for L-threonine production
JPH08322583A (en) Production of l-isoleucine by fermentation method
CN1267734A (en) Process for producing L-amino acid with rod-shaped bacteria through fermentation
CN1296473C (en) Microorganism producing l-threonine, method of producing the same and method of producing l-threonine using the microorganism
JP3239903B2 (en) Creation of new L-threonine-producing bacteria by Escherichia coli and method for producing L-threonine thereby
Igarashi et al. Excretion of L-tryptophan by analogue-resistant mutants of Pseudomonas hydrogenothermophila TH-1 in autotrophic cultures
CN101072865A (en) A microorganism producing l-threonine having an inactivated lysr gene, method for producing the same and method for producing l-threonine using the microorganism
EP1611232B1 (en) tdcBC/pckA GENE-INACTIVATED MICROORGANISM AND METHOD OF PRODUCING L-THREONINE USING THE SAME
JPH0665314B2 (en) Fermentation method for producing L-valine
US7378267B1 (en) Method for L-threonine production
KR100608084B1 (en) A microorganism having an inactivated iclR gene and capable of producing a L-threonine, method for manufacturing the same strain and method for producing L-threonine using the same strain
RU2027761C1 (en) Strain of bacterium brevibacterium sp - a producer of lysine
KR20100038639A (en) Microorganism comprising modified purc gene and process for production method of inosine using the same